Literature DB >> 22917068

[Prescription errors in a neonatal intensive care unit from Buenos Aires].

Vera Vanina Serra1, Fabiana Pena, Maria Fabiana Ossorio, Carlos Pedicone, Marcelo Armadans.   

Abstract

BACKGROUND: Although error could be present in almost every medical practice, they are more frequent and potentially more dangerous in neonatal intensive care units (NICU).
OBJECTIVE: To determine prescription error rate of intravenous drugs in a Neonatal Intensive Care Unit (NICU), and to describe type of error (dose, dilution, and interval) and medication (antibiotics, inotropics, or analgesics).
METHODS: Observational study including medical records of patients hospitalized in a NICU, receiving any of the above mentioned drugs. Each prescription was compared with one provided by a specific software. Prescription error was defined as >10% of difference between both values.
RESULTS: 362 prescriptions from 82 patients were analyzed. An error was observed in 42.5% (95%CI 37.4 - 47.8) of all prescriptions, including 148 (96.1%; 95%CI: 91.3-98.4) antibiotics prescriptions, 5 (3.2%; 95%CI: 1.2-7.7) inotropics prescriptions and 1 (0.7%; 95%CI: 0.01-4.2) analgesics prescriptions. Prescription errors were due to frequency error in 53.8% 95%CI: 45.6-61.8 of cases and to volume error in 46.1% (95%CI: 38.1-54.3).
CONCLUSION: Almost half of the intravenous drugs prescriptions included an error, being more frequently related to interval, followed by dosing; no errors in dilution were detected. Using prescription software could improve patient's safety.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22917068

Source DB:  PubMed          Journal:  Rev Fac Cien Med Univ Nac Cordoba        ISSN: 0014-6722


  1 in total

1.  Medication errors in neonatal intensive care unit of a tertiary care hospital in South India: A prospective observational study.

Authors:  B Prakadeesh Bharathi; Jeffrey Pradeep Raj; Kevin Saldanha; P N Suman Rao; D Padmini Devi
Journal:  Indian J Pharmacol       Date:  2020 Jul-Aug       Impact factor: 1.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.